IISc team develops low-cost diagnostic test for Sickle Cell Disease

IISc team develops low-cost diagnostic test for Sickle Cell Disease

1 min read11 Views Comment FOLLOW USPrefer Shiksha.comShiksha
CallCall 8585951111Got Doubts?
Anupama
Anupama Mehra
Assistant Manager – Content
New Delhi, Updated on Jun 20, 2021 19:05 IST
The diagnostic test developed by the researchers is a low-cost alternative to high-performance liquid chromatography (HPLC). The HPLC test is time-consuming and costs between Rs 400 and Rs 700.

The diagnostic test developed by the researchers is a low-cost alternative to high-performance liquid chromatography (HPLC). The HPLC test is time-consuming and costs between Rs 400 and Rs 700.

A team of researchers at the Indian Institute of Science (IISc), led by Professor Sai Siva Gorthi along with his collaborator Dr. Nisanth Nambisson at Government Homeopathy medical college (GHMC) Bhopal, has developed a new low-cost diagnostic test that can detect Sickle Cell Disease (SCD) and Sickle Cell Trait (SCT).
Sickle Cell Disease (SCD) is an inherited disorder of the red blood cells, which is characterised by repeated episodes of debilitating pain. Other symptoms include chronic anemia, acute chest syndrome, stroke, splenic and renal dysfunction, pain crises, and susceptibility to bacterial infections, the IISc said.

The diagnostic test developed by the researchers is a low-cost alternative to high-performance liquid chromatography (HPLC). The HPLC test is time-consuming and costs between Rs 400 and Rs 700, it said.

The HPOS test developed by the IISc team can be performed in 15 minutes. It is an β€œabsorbance spectroscopy-based test” that uses a machine learning-based algorithm for classifying the samples, the institute said.

Staying updated about the latest educational events is just a click away
Enter Mobile Number

India is estimated to have over 50 per cent of the world’s patients with SCD. β€œThe disease is most prevalent in tribal communities across the central Indian belt extending from south-eastern Gujarat to south-western Odisha,” IISc said in a statement.

β€œOver a million people have sickle cell disease in India today. There are nearly 2,00,000 babies born with the condition every year. The sickle gene is widespread among many tribal population groups in India with the prevalence of the sickle cell trait (SCT) varying from 1-40%. Hence, it is important to screen the population for SCT to lower the prevalence of SCD,” the IISc said.

The institute has informed clinical trials of the new diagnostic tests are being carried out with the help of GHMC, Bhopal and ICMR National Institute of Research on Tribal Health, Jabalpur.

IISc incubated company Shanmukha Innovations Private Limited has licensed the technology and a patent has been filed for the technology, it said.

Read More:

Follow Shiksha.com for latest education news in detail on Exam Results, Dates, Admit Cards, & Schedules, Colleges & Universities news related to Admissions & Courses, Board exams, Scholarships, Careers, Education Events, New education policies & Regulations.
To get in touch with Shiksha news team, please write to us at news@shiksha.com

About the Author
author-image
Anupama Mehra
Assistant Manager – Content

She has over 10 years of experience in the education and publishing sectors. She specialises in exam coverage and content creation. At Shiksha, she writes, analyses, and presents information for students preparing f

Read Full Bio
qna

Comments